Aspiriant Risk-Managed Equity Allocation Fund

Investment Objective

The Aspiriant Risk-Managed Equity Allocation Fund seeks to achieve long-term capital appreciation while considering federal tax implications of investment decisions.

Strategies

Under normal conditions, the Fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in equity securities. The Fund also may invest in securities that provide exposure to equity securities (for example, rights, warrants, futures contracts, swaps, and equity options). The Fund will hold a broad and diverse group of equity securities of companies in countries with developed and emerging markets with greater emphasis on small capitalization and value companies. The Fund may invest in companies of any market capitalization. In addition, the Fund may invest in other derivative instruments to seek return, hedge against fluctuations in securities prices, interest rates or currency exchange rates, as a substitute for the purchase or sale of securities or currencies, or for investment purposes to increase its economic exposure to a particular security, currency or index in a cost effective manner.


Please consider the Fund’s investment objectives, risks, charges and expenses carefully before investing. The prospectus that contains this and other information about the Fund is available by calling 1.877.997.9971 and should be read carefully prior to investing.

An investment in the Fund is subject to risks, and you could lose money on your investment in the Fund. The principal risks of investing in the Fund include, but are not limited to, asset allocation, investing in smaller companies with limited resources and the use of predictive models. Low volatility and quality investing may go in and out of favor which may cause the Fund to sometimes underperform other equity funds. The Fund may invest in illiquid securities, which may or may not be sold or disposed of in the ordinary course of business. Foreign securities, including depositary receipts, have additional risks including currency rate changes, political and economic instability, less regulation and market liquidity. Investments in emerging markets involve even greater risks. The adviser and sub-advisers may be unable to construct the Fund’s investment portfolio such that the intended federal tax implications, when making investment decisions with respect to individual securities, are achieved. As a result of its investments in underlying funds, the Fund is exposed to the principal risks of underlying funds. These risks include counterparty, derivatives, focused investment, large shareholder, leverage and short sale risks. Further information about these and other risks may be found in the prospectus.

Aspiriant Risk-Managed Equity Allocation Fund is distributed by Distribution Services, LLC. Aspiriant, LLC serves as the investment adviser (the “Investment Manager”) of the Fund. Distribution Services, LLC and Aspiriant, LLC are unaffiliated. Check the background of this firm on FINRA’s BrokerCheck

Quick Facts

Ticker Symbol

RMEAX

CUSIP

04537V105

Inception Date

4/4/2013

Fund Assets

$1.41 Billion
(as of 11/30/2024)

Number of Equity Holdings

184 (as of 9/30/2024)

Dividends

Distributed Annually